Maraviroc-containing Regimens Appear Safe for HIV PrEP in Women

Maraviroc-containing regimens appear to be safe and well tolerated, compared with tenofovir-emtricitabine (TDF-FTC), for preventing HIVinfection in women, according to results from a phase 2 trial. Reuters Health Information

More From BioPortfolio on "Maraviroc-containing Regimens Appear Safe for HIV PrEP in Women"

Relevant Topics

Reverse TranscriptaseReverse transcriptase (RT) is an enzyme used to generate complementary DNA (cDNA) from an RNA template, a process termed reverse transcription. It is mainly associated with retroviruses. RT inhibitors are widely used as antiretroviral drugs. RT activitie...